|
|
Name: |
Opaleye Management Inc. |
City: |
Cambridge |
State: |
MA |
Zip: |
02140 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
52 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
HROW |
Harrow Health Inc |
1 |
- |
$10.27 |
$42,784,000 |
3,820,000 |
11.47% |
-11,750,000 |
25,000 |
14.835 |
Biotechnology |
|
TGTX |
TG Therapeutics Inc |
2 |
- |
$13.98 |
$37,832,000 |
2,215,000 |
10.14% |
22,032,000 |
325,000 |
1.718 |
Drug Manufacturers - ... |
|
SLRN |
Acelyrin, Inc. |
3 |
- |
$4.57 |
$30,930,000 |
4,146,138 |
8.29% |
-11,236,000 |
0 |
4.266 |
N/A |
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
4 |
- |
$39.71 |
$28,042,000 |
610,000 |
7.51% |
13,072,000 |
-43,000 |
0.994 |
N/A |
|
OCUL |
Ocular Therapeutix, Inc |
5 |
- |
$0.00 |
$27,072,000 |
6,070,000 |
7.25% |
6,762,000 |
-398,000 |
8.503 |
N/A |
|
CPRX |
Catalyst Pharmaceutical Par... |
6 |
- |
$15.12 |
$21,436,000 |
1,257,200 |
5.74% |
7,350,000 |
52,200 |
1.213 |
Drugs - Generic |
|
KROS |
Keros Therapeutics, Inc. |
7 |
- |
$0.00 |
$14,214,000 |
357,500 |
3.81% |
2,724,000 |
-2,900 |
1.052 |
N/A |
|
IDYA |
Ideaya Biosciences, Inc. |
8 |
- |
$0.00 |
$11,083,000 |
311,500 |
2.97% |
2,679,000 |
0 |
0.647 |
N/A |
|
ETON |
Eton Pharmaceuticals, Inc. |
9 |
- |
$0.00 |
$11,081,000 |
2,529,887 |
2.97% |
947,000 |
99,617 |
14.366 |
N/A |
|
CRNX |
Crinetics Pharmaceuticals, ... |
10 |
- |
$43.32 |
$10,941,000 |
307,500 |
2.93% |
-63,000 |
-62,500 |
0.53 |
N/A |
|
ARVN |
Arvinas Holding Company, Llc |
11 |
New |
$32.54 |
$10,854,000 |
263,700 |
2.91% |
10,854,000 |
263,700 |
0.496 |
N/A |
|
CDXS |
Codexis Inc |
12 |
- |
$2.80 |
$9,289,000 |
3,045,525 |
2.49% |
7,174,000 |
1,926,625 |
4.694 |
Biotechnology |
|
BHVN |
Biohaven Ltd. |
13 |
- |
$38.72 |
$8,560,000 |
200,000 |
2.29% |
-2,858,000 |
-239,000 |
0.293 |
N/A |
|
EWTX |
Edgewise Therapeutics, Inc. |
14 |
- |
$0.00 |
$7,647,000 |
699,000 |
2.05% |
2,631,000 |
-176,405 |
1.001 |
N/A |
|
IOVA |
Iovance Biotherapeutics Inc |
15 |
- |
$11.71 |
$7,293,000 |
897,000 |
1.95% |
4,517,000 |
287,000 |
0.419 |
N/A |
|
ARQT |
Arcutis Biotherapeutics, Inc. |
16 |
New |
$8.75 |
$6,331,000 |
1,960,000 |
1.7% |
6,331,000 |
1,960,000 |
2.61 |
N/A |
|
FDMT |
4d Molecular Therapeutics Inc. |
17 |
- |
$0.00 |
$6,250,000 |
308,500 |
1.67% |
2,323,000 |
0 |
0.952 |
N/A |
|
MRNS |
Marinus Pharmaceuticals Inc |
18 |
- |
$1.44 |
$6,125,000 |
563,500 |
1.64% |
1,424,000 |
-20,500 |
1.136 |
N/A |
|
PCVX |
Vaxcyte, Inc. |
19 |
- |
$0.00 |
$5,652,000 |
90,000 |
1.51% |
1,064,000 |
0 |
0.083 |
N/A |
|
LQDA |
Liquidia Technologies Inc |
20 |
- |
$12.55 |
$5,353,000 |
445,000 |
1.43% |
1,735,000 |
-125,700 |
1.179 |
N/A |
|
TARA |
Protara Therapeutics, Inc |
21 |
- |
$2.82 |
$5,049,000 |
2,692,594 |
1.35% |
552,000 |
0 |
25.619 |
N/A |
|
URGN |
Urogen Pharma Ltd. |
22 |
- |
$14.21 |
$4,800,000 |
320,000 |
1.29% |
317,000 |
0 |
1.449 |
N/A |
|
XOMA |
XOMA Corporation |
23 |
- |
$25.64 |
$4,625,000 |
250,000 |
1.24% |
757,000 |
-24,500 |
2.218 |
Biotechnology |
|
APLT |
Applied Therapeutics Inc. |
24 |
- |
$0.00 |
$3,660,000 |
1,092,500 |
0.98% |
1,436,000 |
199,500 |
2.276 |
N/A |
|
RLMD |
Relmada Therapeutics, Inc. |
25 |
- |
$3.86 |
$3,631,000 |
877,000 |
0.97% |
3,541,000 |
847,000 |
3.163 |
N/A |
|
BDSX |
Biodesix Inc |
26 |
- |
$0.00 |
$3,611,000 |
496,500 |
0.97% |
573,000 |
40,927 |
1.871 |
N/A |
|
TRVI |
Trevi Therapeutics, Inc. |
27 |
- |
$0.00 |
$3,397,000 |
2,535,000 |
0.91% |
-322,000 |
829,100 |
4.231 |
N/A |
|
JSPR |
Jasper Therapeutics Ord Shs |
28 |
New |
$15.12 |
$3,144,000 |
3,985,340 |
0.84% |
3,144,000 |
3,985,340 |
3.923 |
N/A |
|
NTLA |
Intellia Therapeutics, Inc. |
29 |
- |
$21.17 |
$3,019,000 |
99,000 |
0.81% |
3,019,000 |
99,000 |
0.111 |
N/A |
|
NAMS |
Newamsterdam Pharma Ord Shs |
30 |
New |
$0.00 |
$2,964,000 |
265,388 |
0.79% |
2,964,000 |
265,388 |
0.325 |
N/A |
|
LRMR |
Larimar Therapeutics Inc |
31 |
- |
$1.15 |
$2,837,000 |
623,500 |
0.76% |
-515,000 |
-225,000 |
1.561 |
N/A |
|
VTYX |
Ventyx Biosciences, Inc. |
32 |
New |
$4.24 |
$2,816,000 |
1,140,000 |
0.75% |
2,816,000 |
1,140,000 |
2.267 |
N/A |
|
SYRS |
Syros Pharmaceuticals, Inc. |
33 |
New |
$5.07 |
$2,799,000 |
359,370 |
0.75% |
2,799,000 |
359,370 |
0.639 |
N/A |
|
GOSS |
Gossamer Bio Inc |
34 |
- |
$0.71 |
$2,721,000 |
2,982,200 |
0.73% |
-1,238,000 |
-1,772,000 |
3.156 |
N/A |
|
PTGX |
Protagonist Therapeutics, Inc |
35 |
New |
$25.70 |
$2,584,000 |
112,700 |
0.69% |
2,584,000 |
112,700 |
0.2 |
N/A |
|
KALV |
Kalvista Pharmaceuticals Inc |
36 |
- |
$10.35 |
$1,838,000 |
150,000 |
0.49% |
-2,977,000 |
-350,000 |
0.444 |
N/A |
|
VSTM |
Verastem, Inc. |
37 |
- |
$9.31 |
$1,721,000 |
211,400 |
0.46% |
2,000 |
0 |
0.838 |
Biotechnology |
|
NYXH |
Nyxoah Ord Shs |
38 |
- |
$0.00 |
$1,600,000 |
344,800 |
0.43% |
-1,515,000 |
-97,096 |
1.35 |
N/A |
|
MOR |
Morphosys Ag |
39 |
- |
$18.05 |
$1,436,000 |
145,000 |
0.38% |
-6,691,000 |
-1,064,380 |
0.111 |
N/A |
|
PGEN |
Precigen Inc |
40 |
- |
$1.42 |
$1,357,000 |
1,012,500 |
0.36% |
39,000 |
84,000 |
0.567 |
Biotechnology |
|
STRO |
Sutro Biopharma Inc |
41 |
- |
$3.47 |
$1,293,000 |
301,491 |
0.35% |
1,293,000 |
301,491 |
0.536 |
N/A |
|
CNTX |
Context Therapeutics Inc. |
42 |
New |
$0.00 |
$1,102,000 |
975,000 |
0.3% |
1,102,000 |
975,000 |
6.109 |
N/A |
|
FULC |
Fulcrum Therapeutics, Inc. |
43 |
- |
$0.00 |
$878,000 |
130,000 |
0.24% |
878,000 |
130,000 |
0.206 |
N/A |
|
ALGS |
Aligos Therapeutics, Inc. |
44 |
New |
$0.00 |
$861,000 |
1,297,000 |
0.23% |
861,000 |
1,297,000 |
3.703 |
N/A |
|
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
45 |
New |
$17.86 |
$640,000 |
37,500 |
0.17% |
640,000 |
37,500 |
0.111 |
N/A |
|
IGMS |
Igm Biosciences, Inc. |
46 |
Closed |
$0.00 |
$0 |
0 |
0% |
-2,179,000 |
-261,000 |
0 |
N/A |
|
KZR |
Kezar Life Sciences, Inc. |
51 |
Closed |
$0.80 |
$0 |
0 |
0% |
-506,000 |
-425,000 |
0 |
N/A |
|
GERN |
Geron Corporation |
50 |
Closed |
$3.58 |
$0 |
0 |
0% |
-4,060,000 |
-1,915,000 |
0 |
Drug Manufacturers - ... |
|
FBIO |
Fortress Biotech, Inc. |
52 |
Closed |
$0.29 |
$0 |
0 |
0% |
-581,000 |
-2,000,000 |
0 |
Biotechnology |
|
TELA |
Tela Bio, Inc. |
49 |
Closed |
$4.45 |
$0 |
0 |
0% |
-6,000,000 |
-750,000 |
0 |
N/A |
|
TCON |
Tracon Pharmaceuticals, Inc. |
48 |
Closed |
$0.26 |
$0 |
0 |
0% |
-848,000 |
-4,764,508 |
0 |
N/A |
|
XERS |
Xeris Pharmaceuticals Inc |
47 |
Closed |
$1.76 |
$0 |
0 |
0% |
-725,000 |
-390,000 |
0 |
N/A |
|